These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 9070314)

  • 21. Differential expression of CD44 during human prostate epithelial cell differentiation.
    Alam TN; O'Hare MJ; Laczkó I; Freeman A; Al-Beidh F; Masters JR; Hudson DL
    J Histochem Cytochem; 2004 Aug; 52(8):1083-90. PubMed ID: 15258184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of epitopes CD44v3 and CD44v6 in the invasive behavior of fibroblast-like synoviocytes derived from rheumatoid arthritic joints.
    Wibulswas A; Croft D; Pitsillides AA; Bacarese-Hamilton I; McIntyre P; Genot E; Kramer IM
    Arthritis Rheum; 2002 Aug; 46(8):2059-64. PubMed ID: 12209509
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapid analysis of distinctive CD44 RNA splicing preferences that characterize colonic tumors.
    Goodison S; Yoshida K; Sugino T; Woodman A; Gorham H; Bolodeoku J; Kaufmann M; Tarin D
    Cancer Res; 1997 Aug; 57(15):3140-4. PubMed ID: 9242440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel CD44 messenger RNA isoforms in human thyroid and breast tissues feature unusual sequence rearrangements.
    Ermak G; Jennings T; Boguniewicz A; Figge J
    Clin Cancer Res; 1996 Aug; 2(8):1251-4. PubMed ID: 9816294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tissue specific expression of alternatively spliced murine PECAM-1 isoforms.
    Sheibani N; Sorenson CM; Frazier WA
    Dev Dyn; 1999 Jan; 214(1):44-54. PubMed ID: 9915575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alternative splicing variations in mouse CAPS2: differential expression and functional properties of splicing variants.
    Sadakata T; Washida M; Furuichi T
    BMC Neurosci; 2007 Apr; 8():25. PubMed ID: 17428348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD44 isoform expression follows two alternative splicing pathways in breast tissue.
    Roca X; Mate JL; Ariza A; Muñoz-Mármol AM; von Uexküll-Güldeband C; Pellicer I; Navas-Palacios JJ; Isamat M
    Am J Pathol; 1998 Jul; 153(1):183-90. PubMed ID: 9665479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of CD44 isoforms in human breast carcinoma xenografts is not influenced by the treatment of mice with cytostatics or (anti-)hormones.
    Dehmel A; Becker M; Lemm M; Fichtner I
    Anticancer Res; 1999; 19(3A):1977-87. PubMed ID: 10470143
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alternative mRNA splicing in colon cancer causes loss of expression of neural cell adhesion molecule.
    Huerta S; Srivatsan ES; Venkatesan N; Peters J; Moatamed F; Renner S; Livingston EH
    Surgery; 2001 Nov; 130(5):834-43. PubMed ID: 11685193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coupling of signal transduction to alternative pre-mRNA splicing by a composite splice regulator.
    König H; Ponta H; Herrlich P
    EMBO J; 1998 May; 17(10):2904-13. PubMed ID: 9582284
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyaluronidase can modulate expression of CD44.
    Stern R; Shuster S; Wiley TS; Formby B
    Exp Cell Res; 2001 May; 266(1):167-76. PubMed ID: 11339835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in CD44 expression during carcinogenesis of the mouse colon.
    Rudzki Z; LeDuy L; Jothy S
    Exp Mol Pathol; 1997 Apr; 64(2):114-25. PubMed ID: 9316589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genomic organization and structure of the 5'-flanking region of the TEX101 gene: alternative promoter usage and splicing generate transcript variants with distinct 5'-untranslated region.
    Tsukamoto H; Takizawa T; Takamori K; Ogawa H; Araki Y
    Mol Reprod Dev; 2007 Feb; 74(2):154-62. PubMed ID: 16941676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A study of CD33 (SIGLEC-3) antigen expression and function on activated human T and NK cells: two isoforms of CD33 are generated by alternative splicing.
    Hernández-Caselles T; Martínez-Esparza M; Pérez-Oliva AB; Quintanilla-Cecconi AM; García-Alonso A; Alvarez-López DM; García-Peñarrubia P
    J Leukoc Biol; 2006 Jan; 79(1):46-58. PubMed ID: 16380601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential expression of CD44 variant isoforms by cell lines and tissue specimens of transitional cell carcinomas.
    Chuang CK; Liao SK
    Anticancer Res; 2003; 23(6C):4635-9. PubMed ID: 14981907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heparan sulfate enhances invasion by human colon carcinoma cell lines through expression of CD44 variant exon 3.
    Kuniyasu H; Oue N; Tsutsumi M; Tahara E; Yasui W
    Clin Cancer Res; 2001 Dec; 7(12):4067-72. PubMed ID: 11751503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Developmentally regulated expression of metastasis-associated antigens in the rat.
    Claas C; Herrmann K; Matzku S; Möller P; Zöller M
    Cell Growth Differ; 1996 May; 7(5):663-78. PubMed ID: 8732676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distinct CD44 splice variants differentially affect collateral artery growth.
    Bot PT; Grundmann S; van Royen N; Joosten SP; Schirmer SH; de Kleijn DP; Pals ST; Pasterkamp G; Piek JJ; Hoefer IE
    Curr Vasc Pharmacol; 2013 Jan; 11(1):13-20. PubMed ID: 23391418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered expression of CD44 isoforms in squamous-cell carcinomas and cell lines derived from them.
    Hudson DL; Speight PM; Watt FM
    Int J Cancer; 1996 May; 66(4):457-63. PubMed ID: 8635860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD44 isoform expression mediated by alternative splicing: tissue-specific regulation in mice.
    Hirano H; Screaton GR; Bell MV; Jackson DG; Bell JI; Hodes RJ
    Int Immunol; 1994 Jan; 6(1):49-59. PubMed ID: 7511928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.